Effect of Renin-Angiotensin System Blockage in Patients with Acute Respiratory Distress Syndrome: A Retrospective Case Control Study

키워드

참고문헌 (49)

1. Ware LB, "The acute respiratory distress syndrome", N Engl J Med, 342, pp.1334~1349 (2000)
2. Bernard GR, "The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination", Am J Respir Crit Care Med, 149(3 Pt 1), pp.818~824 (1994)
3. Krafft P, "The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations", Intensive Care Med, 22, pp.519~529 (1996)
4. Phua J, "Has mortality from acute respiratory distress syndrome decreased over time? A systematic review", Am J Respir Crit Care Med, 179, pp.220~227 (2009)
5. Abel SJ, "Reduced mortality in association with the acute respiratory distress syndrome (ARDS)", Thorax, 53, pp.292~294 (1998)
6. Erickson SE, "Recent trends in acute lung injury mortality: 1996-2005", Crit Care Med, 37, pp.1574~1579 (2009)
7. Pugin J, "The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome", Crit Care Med, 27, pp.304~312 (1999)
8. Marshall R, "The acute respiratory distress syndrome: fibrosis in the fast lane", Thorax, 53, pp.815~817 (1998)
9. McClintock D, "Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury", Crit Care, 12, pp.R41~ (2008)
10. Meduri GU, "Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS:plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time", Chest, 107, pp.1062~1073 (1995)
11. Bhatia M, "Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome", J Pathol, 202, pp.145~156 (2004)
12. Burnham EL, "The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance", Eur Respir J, 43, pp.276~285 (2014)
13. Quesnel C, "Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury", Crit Care Med, 40, pp.21~28 (2012)
14. Martin C, "Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome: a study in mechanically ventilated patients", Chest, 107, pp.196~200 (1995)
15. Kranzhofer R, "Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes", Biochem Biophys Res Commun, 257, pp.826~828 (1999)
16. Hernandez-Presa M, "Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis", Circulation, 95, pp.1532~1541 (1997)
17. Arndt PG, "Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharideinduced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways", J Immunol, 177, pp.7233~7241 (2006)
18. He X, "Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats", Shock, 28, pp.106~111 (2007)
19. Wang R, "Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor", Am J Physiol Lung Cell Mol Physiol, 279, pp.L143~L151 (2000)
20. Cohen EP, "Captopril preserves function and ultrastructure in experimental radiation nephropathy", Lab Invest, 75, pp.349~360 (1996)
21. Molteni A, "Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker", Int J Radiat Biol, 76, pp.523~532 (2000)
22. Brooks WW, "Conrad CH. Effect of angiotensinconverting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat", Circulation, 96, pp.4002~4010 (1997)
23. Ishidoya S, "Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction", Kidney Int, 47, pp.1285~1294 (1995)
24. Schieffer B, "Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat", Circulation, 89, pp.2273~2282 (1994)
25. ARDS Definition Task Force, "Acute respiratory distress syndrome: the Berlin Definition", JAMA, 307, pp.2526~2533 (2012)
26. Frank AJ, "Pharmacological treatments for acute respiratory distress syndrome", Curr Opin Crit Care, 16, pp.62~68 (2010)
27. Heart, "Rosuvastatin for sepsis-associated acute respiratory distress syndrome", N Engl J Med, 370, pp.2191~2200 (2014)
28. Kor DJ, "Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury", Intensive Care Med, 35, pp.1039~1046 (2009)
29. Jaimes F, "Unfractioned heparin for treatment of sepsis: a randomized clinical trial (the HETRASE study)", Crit Care Med, 37, pp.1185~1196 (2009)
30. Kor DJ, "Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of atrisk patients", Crit Care Med, 39, pp.2393~2400 (2011)
31. Rubenfeld GD, "Incidence and outcomes of acute lung injury", N Engl J Med, 353, pp.1685~1693 (2005)
32. Moss M, "Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome", Crit Care Med, 24, pp.1782~1786 (1996)
33. Conner ER, "Elevated pulmonary edema fluid concentrations of soluble intercellular adhesion molecule-1 in patients with acute lung injury: biological and clinical significance", Chest, 116(1 Suppl), pp.83S~84S (1999)
34. Flori HR, "Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation", Pediatr Crit Care Med, 4, pp.315~321 (2003)
35. Parsons PE, "Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury", Crit Care Med, 33, pp.1~6 (2005)
36. Seccia TM, "The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension", J Hypertens, 24, pp.1419~1427 (2006)
37. Yamamoto K, "ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure", J Hypertens, 23, pp.393~400 (2005)
38. Karimian G, "Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats", Biomed Pharmacother, 62, pp.312~316 (2008)
39. Jonsson JR, "Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis", Gastroenterology, 121, pp.148~155 (2001)
40. Needham DM, "Lung protective mechanical ventilation and two year survival in patients with acute lung injury:prospective cohort study", BMJ, 344, pp.e2124~ (2012)
41. Herridge MS, "Oneyear outcomes in survivors of the acute respiratory distress syndrome", N Engl J Med, 348, pp.683~693 (2003)
42. Angel MJ, "Neuromuscular function in survivors of the acute respiratory distress syndrome", Can J Neurol Sci, 34, pp.427~432 (2007)
43. Villar J, "The acute respiratory distress syndrome: incidence and mortality, has it changed?", Curr Opin Crit Care, 20, pp.3~9 (2014)
44. MacCallum NS, "Epidemiology of acute lung injury", Curr Opin Crit Care, 11, pp.43~49 (2005)
45. Soubani AO, "The outcome of cancer patients with acute respiratory distress syndrome", J Crit Care, 29, pp.183.e7~183.e183 (2014)
46. Matchar DB, "Systematic review:comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension", Ann Intern Med, 148, pp.16~29 (2008)
47. Vega IL., "ACE inhibitors vs ARBs for primary hypertension", Am Fam Physician, 91, pp.522~523 (2015)
48. Laverman GD, "ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection?", J Am Soc Nephrol, 15(Suppl 1), pp.S64~S70 (2004)
49. Wang CY, "One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome", Intensive Care Med, 40, pp.388~396 (2014)

관련 논문AI추천